However, Torrent Pharma was hurt due to the closure of an insulin manufacturing facility in August and a 17% on-year depreciation in Brazil's currency, the company said. * Mean of analysts ...

India's Torrent Pharma misses Q3 profit estimates, hurt by insulin plant closure January ... beating analysts' estimates and valuing the company at 18.64 billion rupees ($223.3 million), as ...

(Reuters) - India's Torrent Pharmaceuticals reported a smaller-than-expected third-quarter profit on Friday, hurt by the planned closure of its insulin manufacturing facility. The company ...

(Reuters) - India's Torrent Pharmaceuticals reported a smaller-than-expected third-quarter profit on Friday, hurt by the planned closure of its insulin manufacturing facility. The company, known for ...